SPECIFIC INTERFERENCE WITH NUCLEAR ERK1/2 SIGNALING PREVENTS PATHOLOGICAL CARDIAC HYPERTROPHY

被引：0
|
作者：
Ruppert, C. [1 ,2 ]
Deiss, K. [1 ]
Herrmann, S. [2 ,3 ]
Vidal, M. [1 ]
Oezkur, M. [2 ,4 ]
Gorski, A. [2 ,4 ]
Weidemann, F. [2 ,3 ]
Lohse, M. J. [1 ,2 ]
Lorenz, K. [1 ,2 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany
[2] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[4] Univ Hosp Wurzburg, Dept Thorac Cardiac & Thorac Vasc Surg, Wurzburg, Germany
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [21] IGF-1 REGULATES CARDIAC HYPERTROPHY AND INOS EXPRESSION IN OBESE MALE RATS THROUGH ERK1/2 SIGNALING PATHWAY
    Panic, A.
    Stanimirovic, J.
    Obradovic, M.
    Sudar-Milovanovic, E.
    Isenovic, E. R.
    ATHEROSCLEROSIS, 2018, 275 : E137 - E137
  • [22] Activation Of Erk1/2 Signaling Drives Cardiac Hypertrophy During Chronic Mild Stress-induced Depression In Mice
    Singh, Sarojini
    Patil, Mallikarjun
    Dubey, Praveen
    Dubey, Shubham
    Luong, Hien
    Krishnamurthy, Prasanna
    STROKE, 2022, 53
  • [23] Rescue of the cardiac phenotype of noonan syndrome in vivo by ablation of cardiac ERK1/2 signaling
    Nakamura, Tomoki
    Colbert, Melissa
    Krenz, Maike
    Hahn, Harvey
    Molkentin, Jeffery
    Robbins, Jeffrey
    CIRCULATION, 2006, 114 (18) : 7 - 7
  • [24] Myocardial hypertrophy is prevented by farnesol through oxidative stress and ERK1/2 signaling pathways
    Souza, Diego Santos
    Barreto, Tatiane de Oliveira
    Rodrigues de Menezes-Filho, Jose Evaldo
    Heimfarth, Luana
    Rhana, Paula
    Rabelo, Thallita Kelly
    Santos Santana, Michael Nadson
    Durco, Aimee Obolari
    de Lima Conceicao, Michael Ramon
    Quintans-Junior, Lucindo Jose
    Guimaraes, Adriana Gibara
    Cruz, Jader Santos
    Lins de Vasconcelos, Carla Maria
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 887
  • [25] Repression of ERK1/2 signaling by RanBPM
    Atabakhsh, Elnaz
    Schild-Poulter, Caroline
    CANCER RESEARCH, 2011, 71
  • [26] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Dolinsky, Vernon W.
    Soltys, Carrie-Lynn M.
    Rogan, Kyle J.
    Chan, Anita Y. M.
    Nagendran, Jeevan
    Wang, Shaohua
    Dyck, Jason R. B.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (04): : 413 - 425
  • [27] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Vernon W. Dolinsky
    Carrie-Lynn M. Soltys
    Kyle J. Rogan
    Anita Y. M. Chan
    Jeevan Nagendran
    Shaohua Wang
    Jason R. B. Dyck
    Journal of Molecular Medicine, 2015, 93 : 413 - 425
  • [28] Brain targeted ACE2 overexpression prevents DOCA-salt hypertension and cardiac hypertrophy by modulating NOS and ERK1/2 phosphorylation
    Sriramula, Srinivas
    Xia, Huijing
    Lazartigues, Eric
    FASEB JOURNAL, 2013, 27
  • [29] Inhibition of ERK1/2 signaling prevents epileptiform behavior in rats prone to audiogenic seizures
    Glazova, Margarita V.
    Nikitina, Liubov S.
    Hudik, Kirill A.
    Kirillova, Olga D.
    Dorofeeva, Nadezhda A.
    Korotkov, Anatoly A.
    Chernigovskaya, Elena V.
    JOURNAL OF NEUROCHEMISTRY, 2015, 132 (02) : 218 - 229
  • [30] Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
    Song, Renxing
    Xiong, Chunming
    Bai, Juncai
    Bai, Zhenzhou
    Liu, Wei
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
12345